CRNX (Crinetics Pharmaceuticals, Inc.) Institutional Ownership Summary
Based on the latest SEC 13F filings, 4 institutional investors hold CRNX (Crinetics Pharmaceuticals, Inc.) with a combined value of $570.65M across 12,258,871 shares. The largest holder is BlackRock, Inc. with a position worth $371.87M (0.01% of their portfolio). 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$570.65M
Total Shares Held
12,258,871
Institutional Holders
4
13F Institutional Holders
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $371.87M | 0.01% | +5.3% |
| 2 | Point72 Asset Management, L.P. | $108.79M | 0.12% | +16.7% |
| 3 | BAKER BROS. ADVISORS LP | $76.75M | 0.45% | +488.9% |
| 4 | CITADEL ADVISORS LLC | $13.24M | 0.00% | -72.4% |